News

Study results indicate that clinicians start prescribing new drugs off-label almost as soon as the drugs become available.

The new vaccine schedule is 7 days between doses for adults aged 18 to 65, instead of the standard 28 days.

First large-scale study on trends in invasive candidiasis finds species distribution of isolates varied between blood and nonblood sterile sites.

Delafloxacin was found to be relatively safe and well tolerated in patients with acute bacterial skin and skin structure infections with past or present cardiac or vascular difficulties.

A new analysis details the substantial burden of candidemia in the United States and calls for ongoing surveillance efforts to help assess the impact of prevention interventions.

Over one-third of patients with invasive aspergillosis lacked a documented immunosuppressive condition.

Telemedicine encounters in which antibiotics were prescribed for respiratory tract infections were only slightly shorter than those in which non-antibiotics, or nothing at all, were prescribed.

George Thompson, MD, principal investigator of the STRIVE study discusses optimal dosing for rezafungin in treating candidemia and/or invasive candidiasis.

Researcher give insight into the importance of antibiograms in outpatient management of urinary tract infections

Mary Choi, MD, MPH, discusses the progress made in treating and preventing Ebola and the challenges of fighting the community resistance of the Congolese.

Nonadherence to antiretroviral therapy was associated with a higher risk of death.

A look into the challenges of including infection preventionists in antimicrobial stewardship programs.

The FDA has approved omadacycline (NUZYRA) as an intravenous and oral treatment option for adults with ABSSSI and CABP.

The results of a new study suggest the approach can help stratify patients with the disease.

Scientists have identified a new strategy to generate novel antibiotics.

Despite current recommendations, Tdap vaccine coverage in pregnant women remains suboptimal.

The Contagion® editorial staff will be providing exclusive written and video coverage from ID Week 2018.

While conducting passive surveillance of triazole-resistant Aspergillus fumigatus cases, the CDC observed some cases occurred in patients who had never taken the antifungal medication.

In September 2017, a patient in Hong Kong was diagnosed with rat hepatitis E virus after inflammation of the liver was observed.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

The US Food and Drug Administration has approved Arikayce for the treatment of lung disease caused by Mycobacterium avium complex (MAC) bacteria in a limited population of patients who do not respond to conventional treatment.

In case you missed them, we've compiled the top five infectious disease articles from this past week.

New surveillance report sheds light on meningococcal disease rates among HIV-infected MSM.

In allogenic hematopoietic cell transplant patients, auto-FMT treatment led to the recovery of beneficial gut bacteria close to baseline levels within days.

Plenty of research has gone into the causes and progression of Alzheimer’s disease. Now a new effort aims to make the case that scientists have been looking in the wrong direction.

A new report from the CDC underscores the need for all pregnant women to receive early prenatal care that includes syphilis testing at their first visit.

Contamination is a common aspect of nasal saline irrigations.

Using an algorithm to determine course of treatment shortened antibiotic use by 2 days for patients with uncomplicated staphylococcal bacteremia infections.